Table 4.
Correlation between assessments at A1 and A2 (n = 15).
| Measurements | Spearman's rho | Sig. | |
|---|---|---|---|
| Assessment 1 | |||
| ASRS vs. | A-NING | −0.83** | <0.001 |
| FM-UE | −0.46 | 0.08 | |
| NVOA | −0.58* | 0.02 | |
| BNT | −0.92** | <0.001 | |
| Lesion volume | −0.18 | 0.55 | |
| FM-UE vs. | A-NING | 0.45 | 0.10 |
| NVOA | 0.64* | 0.01 | |
| BNT | 0.48 | 0.07 | |
| Lesion volume | −0.01 | 0.96 | |
| A-NING vs. | BNT | 0.89** | <0.001 |
| NVOA | 0.68** | 0.005 | |
| Lesion volume | 0.02 | 0.95 | |
| NVOA vs. | BNT | 0.72** | 0.003 |
| Lesion volume | −0.21 | 0.48 | |
| BNT vs. | Lesion volume | 0.11 | 0.71 |
| Assessment 2 | |||
| ASRS vs. | A-NING | −0.83** | <0.001 |
| FM-UE | −0.57* | 0.03 | |
| NVOA | −0.71** | 0.003 | |
| BNT | −0.68** | 0.005 | |
| Lesion volume | −0.09 | 0.76 | |
| FM-UE vs. | A-NING | 0.71** | 0.003 |
| NVOA | 0.69** | 0.004 | |
| BNT | 0.80** | <0.001 | |
| Lesion volume | −0.01 | 0.97 | |
| A-NING vs. | BNT | 0.94** | <0.001 |
| NVOA | 0.94** | <0.001 | |
| Lesion volume | 0.01 | 0.98 | |
| NVOA vs. | BNT | 0.94** | <0.001 |
| Lesion volume | −0.16 | 0.59 | |
| BNT vs. | Lesion volume | −0.04 | 0.90 |
*
Significant at p < 0.05,
**
Significant at p < 0.01.